Dr. Junaid Arshad is a physician-scientist and medical oncologist specializing in neuroendocrine tumors (NETs) and gastroesophageal cancers. He serves as Associate Professor of Medicine and Director of the NET Program and NET Service Line at the University of Miami, where his focus is on building a state-of-the-art clinical trial program and tertiary referral center, encompassing NCTN cooperative group studies, industry-sponsored trials, and investigator-initiated trials (IITs).
Dr. Arshad previously founded the NET Program at the University of Arizona Cancer Center (UACC), where he built a comprehensive clinical and research infrastructure for neuroendocrine tumor patients, secured both internal and external funding, and received numerous awards for his contributions. His research interests include chromatin remodeler biology in pancreatic NETs, antibody-drug conjugate binding novel targets, and novel therapeutic strategies for rare and refractory neuroendocrine malignancies.
Dr. Arshad is committed to advancing the field of neuroendocrine and gastrointestinal oncology through rigorous clinical trial design, translational research, and multidisciplinary patient care.
